• KOL
    • Cancer Incidence
    • Jacques Ferlay
    • Jacques Ferlay: Influence Statistics

      Jacques Ferlay

      Jacques Ferlay

      Show email address

      Cancer Surveillance Branch, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France | International Agency for Research on Cancer ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Jacques Ferlay:Expert Impact

      Concepts for whichJacques Ferlayhas direct influence:Cancer incidence,Cervical cancer,Incidence rates,Breast cancer,Lung cancer,Global burden,Latin america,Prostate cancer.

      Jacques Ferlay:KOL impact

      Concepts related to the work of other authors for whichfor which Jacques Ferlay has influence:Breast cancer,Hepatocellular carcinoma,Cell proliferation,Gene expression.

      KOL Resume for Jacques Ferlay

      Year
      2022

      Cancer Surveillance Branch, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France

      2021

      International Agency for Research on Cancer, Lyon, France

      2020

      Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France

      2019

      Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

      2018

      Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Electronic address:

      2017

      Section of Cancer Surveillance, International Agency for Research on Cancer, 69372, Lyon, France

      2016

      Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, Cedex 08, France, .

      International Agency for Research on Cancer, 69372 Lyon Cedex 08, France

      2015

      International Agency for Research on Cancer Informatics Officer, Section of Cancer Surveillance Lyon France

      2014

      Authors' Affiliations: African Cancer Registry Network, INCTR African Registry Programme; Clinical Trials Service Unit & Epidemiological Studies Unit, Nuffield Department of Public Health, University of Oxford, Richard Doll Building, Oxford, United Kingdom; Section of Cancer Information, International Agency for Research on Cancer, Lyon, France; and Surveillance & Health Services Research, American Cancer Society, Inc., Atlanta, Georgia.

      International Agency for Research on Cancer Section of Cancer Surveillance Lyon France

      2013

      Section of Cancer Information (CIN), International Agency for Research on Cancer (IARC), 69008, Lyon, France

      2012

      International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

      2011

      Informatics Officer, Section of Cancer Information, International Agency for Research on Cancer, Lyon, France

      2010

      Descriptive Epidemiology, Data Analysis and Interpretation Group, International Agency for Research on Cancer, Lyon, France

      2009

      International Agency for Research on Cancer, Lyon 69008, France

      2008

      Data Analysis and Interpretation Group and Epidemiology Methods and Support Group, International Agency for Research on Cancer, Lyon, France

      2007

      International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon Cedex 08, Lyon, France

      2006

      staff scientist at the International Agency for Research on Cancer, Lyon, France

      2005

      Ferlay is Informatics Officer, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France

      2002

      Unit of Descriptive Epidemiology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France

      2001

      Descriptive Epidemiology Unit, International Agency for Research on Cancer, Lyon, France

      1999

      Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France

      1997

      International Agency for Research on Cancer, 150 Cours Albert-Thomas, 69372 Lyon Cedex 08, France.

      1996

      †Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Hospital, Chiang Mai

      1995

      International Agency for Research on Cancer, Unit of Descriptive Epidemiology, 150, cours Albert Thomas, 69372 Lyon Cedex 08, France

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Jacques Ferlay is among the top experts in the world.
      Concept World rank
      5 incidence rates #1
      subtype distributions estimates #1
      hcc eastern asia #1
      proportions oesophageal adenocarcinoma #1
      globally aged #1
      275000 deaths #1
      sources methods #1
      frequent cancers women #1
      asr southeastern asia #1
      asia cardia #1
      adenocarcinoma highest #1
      average ratio populations #1
      estimates hcc #1
      global demographic projections #1
      increasing burden cancer #1
      52 prevalent cases #1
      1450000 cases #1
      cancer control policies #1
      burden europe #1
      cgc asr #1
      cancer common cancers #1
      africa epstein barr #1
      412900 129 #1
      icca asr #1
      eu25 deaths #1
      escc ncgc #1
      ncgc cgc #1
      cancer patterns burden #1
      230000 new cases #1
      volume ci5 #1
      1703000 deaths #1
      85 000 oacs #1
      estimated 181 #1
      countries ncgc cgc #1
      cancer observatory #1
      quartiles obesity #1
      decreasing trend rates #1
      estimated 5 deaths #1
      agegroups brazil #1
      530000 new cases #1
      major cancers women #1
      cancers presented #1
      cancer occurrence sexes #1
      liver cancer subtype #1
      males esophageal adenocarcinoma #1
      estimates 40 countries #1
      76 cancer deaths #1
      386300 121 #1
      asr cgc #1
      liver cancer cancers #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Jacques Ferlay

      KOL-Index: 22556

      BACKGROUND: Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality ...

      Known for Cancer Survival | New Zealand | Incidence Mortality | Highincome Countries | Denmark Ireland
      KOL-Index: 21409

      Cancer incidence and mortality estimates for 1995 are presented for the 38 countries in the four United Nations-defined areas of Europe, using World Health Organization mortality data and published estimates of incidence from national cancer registries. Additional estimation was required where national incidence data was not available, and the method involved incorporating the high quality incidence and mortality data available from the expanding number of population-based cancer ...

      Known for Cancer Incidence | Eastern European | Highest Rates | Colon Rectum | Czech Republic
      KOL-Index: 17114

      BACKGROUND: The overall incidence of colorectal cancer is decreasing in many high-income countries, yet analyses in the USA and other high-income countries such as Australia, Canada, and Norway have suggested increasing incidences among adults younger than 50 years. We aimed to examine longitudinal and generational changes in the incidence of colon and rectal cancer in seven high-income countries.

      METHODS: We obtained data for the incidence of colon and rectal cancer from 21 ...

      Known for Rectal Cancer | New Zealand | Australia Canada | Income Countries | Data Incidence
      KOL-Index: 16838

      INTRODUCTION: Cancer incidence and mortality estimates for 25 cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for the European Union (EU-27) for 2012.

      METHODS: We used statistical models to estimate national incidence and mortality rates in 2012 from recently-published data, predicting incidence and mortality rates for the year 2012 from recent trends, wherever possible. The estimated rates in 2012 were applied to the corresponding ...

      Known for 40 Countries | Cancer Europe | Mortality Patterns | New Cases | Female Breast
      KOL-Index: 16509

      BACKGROUND: The knowledge that persistent human papillomavirus (HPV) infection is the main cause of cervical cancer has resulted in the development of prophylactic vaccines to prevent HPV infection and HPV assays that detect nucleic acids of the virus. WHO has launched a Global Initiative to scale up preventive, screening, and treatment interventions to eliminate cervical cancer as a public health problem during the 21st century. Therefore, our study aimed to assess the existing burden ...

      Known for Cervical Cancer | Incidence Mortality | 185 Countries | Hpv Infection | 100 000 Women
      KOL-Index: 16479

      This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, ...

      Known for Global Cancer | 185 Countries | Incidence Mortality | Globocan Estimates | Death Child Child
      KOL-Index: 15690

      BACKGROUND: There are no recent estimates of the incidence and mortality from cancer at a European level. Those data that are available generally refer to the mid-1990s and are of limited use for cancer control planning. We present estimates of the cancer burden in Europe in 2004, including data for the (25 Member States) European Union.

      METHODS: The most recent sources of incidence and mortality data available in the Descriptive Epidemiology Group at IARC were applied to population ...

      Known for Cancer Incidence | Mortality Europe | Incident Cases | Lung Colorectal | Population Projections
      KOL-Index: 15265

      BACKGROUND: Monitoring the evolution of the cancer burden in Europe is of great value. Estimates of the cancer burden in Europe have been published for 2004 and estimates are now being presented for cancer incidence and mortality in Europe for 2006.

      METHODS: The most recent sources of cancer incidence and mortality data have been collected and projections have been carried out using short-term prediction methods to produce estimated rates for 2006. Additional estimation was required ...

      Known for Cancer Incidence | Mortality Europe | Common Form | Cases Colorectal
      KOL-Index: 15196

      INTRODUCTION: Europe contains 9% of the world population but has a 25% share of the global cancer burden. Up-to-date cancer statistics in Europe are key to cancer planning. Cancer incidence and mortality estimates for 25 major cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for Europe and the European Union (EU-28) for 2018.

      METHODS: Estimates of national incidence and mortality rates for 2018 were based on statistical models applied to ...

      Known for Cancer Incidence | 40 Countries | Europe 2018 | 25 Major | Child Child
      KOL-Index: 15144

      The Chernobyl accident, which occurred April 26, 1986, resulted in a large release of radionuclides, which were deposited over a very wide area, particularly in Europe. Although an increased risk of thyroid cancer in exposed children has been clearly demonstrated in the most contaminated regions, the impact of the accident on the risk of other cancers as well as elsewhere in Europe is less clear. The objective of the present study was to evaluate the human cancer burden in Europe as a ...

      Known for Chernobyl Accident | Radioactive Fallout | Thyroid Cancer | Neoplasms Radiation | Incidence Mortality
      KOL-Index: 15103

      BACKGROUND: To date, the burden of cancer among young adults has rarely been studied in depth. Our aim was to describe the scale and profile of cancer incidence and mortality worldwide among 20-39 year-olds, highlighting major patterns by age, sex, development level, and geographical region.

      METHODS: We did a population-based study to quantify the burden of young adult cancers worldwide. We defined young adult cancers as those occurring between the ages of 20 and 39 years because these ...

      Known for Cancer Incidence | Geographical Region | Mortality Young Adults | 39 Years | Development Level
      KOL-Index: 14534

      Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths ...

      Known for Developed Countries | Leading Cancer Death | Cancer Males | Liver Stomach | Physical Inactivity
      KOL-Index: 14528

      OBJECTIVES: As part of the International Cancer Benchmarking Partnership (ICBP) SURVMARK-2 project, we provide the most recent estimates of colon and rectal cancer survival in seven high-income countries by age and stage at diagnosis.

      METHODS: Data from 386 870 patients diagnosed during 2010-2014 from 19 cancer registries in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK) were analysed. 1-year and 5-year net survival from colon and rectal cancer were ...

      Known for Rectal Cancer | Stage Diagnosis | New Zealand | Income Countries | Year Survival
      KOL-Index: 13496

      BACKGROUND: Individual country- and cancer site-specific studies suggest that the age-adjusted incidence of many common cancers has increased in European populations over the past two decades. To quantify the extent of these trends and the recent burden of cancer, here we present a comprehensive overview of trends in population-based incidence of the five common cancers across Europe derived from a new web-based portal of the European cancer registries.

      METHODS: Data on incidence for ...

      Known for Common Cancers | European Cancer Observatory | Trends Incidence | Cancer Registries | Corpus Uteri
      KOL-Index: 13220

      Members of the European Network of Cancer Registries (ENCR) provide population-based data on cancer incidence for some countries and regions of Europe. These were supplemented by estimates in order to provide comparable information on cancer incidence and mortality in the 15 member states of the European Union (EU). The estimated numbers of new cases of cancer (excluding nonmelanoma skin cancer) in 1990 were approximately 706,900 in men and 644,200 in women. Approximately 497,500 men and ...

      Known for Cancer Incidence | European Union | Greece Spain | Western Europe | Rates Females

      Key People For Cancer Incidence

      Top KOLs in the world
      #1
      Ahmedin M Jemal
      united states breast cancer addis ababa
      #2
      Freddie Ian Bray
      cancer incidence nordic countries mortality rates
      #3
      Jacques Ferlay
      cancer incidence global burden latin america
      #4
      Donald Maxwell Parkin
      cancer incidence northeast thailand united kingdom
      #5
      Paolo L Boffetta
      lung cancer occupational exposure pooled analysis
      #6
      Elizabeth M Ward
      united states cancer incidence insurance status

      Cancer Surveillance Branch, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France | International Agency for Research on Cancer (IARC/WHO), Lyon, France | Cancer Surveillance Branch, International Agency fo

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.